Cyclerion Therapeutics (CYCN) Operating Margin (2019 - 2025)
Historic Operating Margin for Cyclerion Therapeutics (CYCN) over the last 6 years, with Q3 2025 value amounting to 114.97%.
- Cyclerion Therapeutics' Operating Margin rose 4664700.0% to 114.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 127.25%, marking a year-over-year increase of 29268700.0%. This contributed to the annual value of 181.4% for FY2024, which is N/A changed from last year.
- Per Cyclerion Therapeutics' latest filing, its Operating Margin stood at 114.97% for Q3 2025, which was up 4664700.0% from 1797.85% recorded in Q2 2025.
- In the past 5 years, Cyclerion Therapeutics' Operating Margin ranged from a high of 27.8% in Q4 2024 and a low of 21604.84% during Q1 2021
- In the last 4 years, Cyclerion Therapeutics' Operating Margin had a median value of 1798.77% in 2025 and averaged 3505.29%.
- In the last 5 years, Cyclerion Therapeutics' Operating Margin crashed by -195743700bps in 2021 and then skyrocketed by 197786800bps in 2022.
- Quarter analysis of 4 years shows Cyclerion Therapeutics' Operating Margin stood at 2690.06% in 2021, then tumbled by -63bps to 4389.87% in 2022, then skyrocketed by 101bps to 27.8% in 2024, then plummeted by -514bps to 114.97% in 2025.
- Its last three reported values are 114.97% in Q3 2025, 1797.85% for Q2 2025, and 1798.77% during Q1 2025.